Prabhudas Lilladher (PL Capital) has upgraded SBI Life Insurance to a BUY rating with a target price of Rs 2,200, implying meaningful upside from the current market price of Rs 1,885. SBI Life Insurance has delivered a resilient operational performance in Q4FY26, marked by steady premium growth, improving product mix, and a strategic pivot toward protection-led expansion. While margins experienced short-term compression due to regulatory changes—specifically GST-related impacts—the broader outlook remains constructive. The company is expected to sustain a robust APE CAGR of approximately 13% over FY26–FY28, supported by strong traction in protection, annuity, and participating products. Embedded value growth remains healthy, and valuation has been recalibrated to a more conservative multiple. With improving distribution dynamics and margin normalization expected, the stock presents an attractive long-term investment opportunity.

Strong Premium Growth Driven by Protection and Annuity Segments

APE growth remains structurally robust: SBI Life reported a 5% YoY increase in Q4FY26 APE to Rs 57.4 billion, driven largely by a sharp 30% YoY surge in retail protection.

Full-year momentum intact: FY26 APE expanded by 13% YoY, with management guiding for a similar trajectory over the next two years.

Product mix evolution: Growth is increasingly led by higher-margin segments—protection, annuity, and PAR—while ULIP growth remains muted due to market volatility and shifting customer preferences.

Segmental composition: ULIP still dominates at 52.1% of APE, followed by non-par (20.2%), protection (10.1%), and annuity (3.5%), reflecting gradual diversification.

Margins Under Pressure, But Recovery Path Clearly Defined

Temporary compression observed: VNB margin declined to 28.4% in Q4FY26 and 27.5% for FY26, primarily due to GST-related disruptions.

Gradual normalization ahead: Margins are projected to improve to 27.6% in FY27 and 27.7% in FY28 as the GST impact fades and product mix improves.

Strategic shift supports profitability: Increased contribution from protection and rider attachments is expected to structurally enhance margins.

Management guidance remains stable: The company continues to target a VNB margin band of 26%–28%, indicating operational discipline.

Distribution Strategy: Agency Expansion and Direct Channel Focus

Channel diversification underway: Banca channel contribution declined to 52.3%, while agency grew strongly at 34.7%, reflecting strategic recalibration.

Agency channel gaining prominence: Agency APE grew 28% YoY, supported by a 24% increase in agent count and improved productivity.

Direct channel investments accelerating: The addition of 120 new branches in FY26 highlights management’s commitment to strengthening offline distribution.

Future mix evolution: Agency contribution is expected to increase by 3–4% over the next few years, enhancing margin resilience.

Embedded Value Growth Remains a Core Strength

EV expansion continues: Embedded Value grew 15% YoY to Rs 808 billion, driven by favorable mortality and persistency trends.

Operating performance stable: EV operating profit stood at Rs 138.7 billion in FY26, reflecting consistent underlying business strength.

Persistency trends mixed: While long-term persistency improved across most cohorts, the 61-month ratio dipped to 58.1% due to pandemic-era cohorts.

Solvency remains comfortable: At 190%, solvency is well above regulatory requirements, despite increased protection underwriting.

Valuation Framework Points to Upside Potential

Target price anchored in appraisal value: The valuation is based on a sum of structural value and embedded value framework.

Valuation reset offers entry opportunity: The stock is now valued at 2.0x FY28E P/EV, down from earlier assumptions of 2.5x, making risk-reward more favorable.

Key Financial Snapshot: Stability with Measured Growth

Premium growth trajectory: Net premium is expected to rise from Rs 999.6 billion in FY26 to Rs 1,338.3 billion by FY28.

Profitability outlook: PAT is projected to recover strongly to Rs 28.7 billion in FY28 after a modest dip in FY27.

Asset expansion: AUM grew 9% YoY to Rs 4,871.6 billion, reflecting steady inflows and market stability.

Return metrics: RoEV is expected to gradually moderate from 19.7% in FY26 to 17.8% in FY28, indicating normalization after high-growth years.

Investment Thesis: Structural Growth Meets Valuation Comfort

Consistent growth visibility: APE CAGR of ~13% provides strong revenue predictability over the medium term.

Margin resilience: Despite near-term pressure, margins are expected to stabilize within guided bands.

Strategic product mix shift: Increasing focus on protection and annuity enhances long-term profitability.

Distribution strength: Expanding agency and direct channels reduce dependence on banca.

Attractive valuation: Lower P/EV multiple offers a compelling entry point for long-term investors.

Risks to Monitor

Regulatory uncertainties: Changes such as open architecture in banca distribution could impact channel dynamics.

Market-linked volatility: ULIP performance remains sensitive to equity market fluctuations.

Persistency challenges: Any further deterioration in long-term persistency ratios could affect profitability.

Bottomline: BUY with a Medium-Term Upside Target of Rs 2,200

SBI Life Insurance stands at a critical inflection point where growth visibility, product diversification, and improving distribution dynamics converge. While short-term headwinds—particularly regulatory and margin-related—remain, the structural story is intact. The recalibrated valuation framework, coupled with steady embedded value accretion, positions the stock as an attractive opportunity in the life insurance space.